Vishakhapatnam : Marking the birth anniversary of Dr A.P.J. Abdul Kalam, the Andhra Pradesh MedTech Zone (AMTZ) and its research arm the Kalam Institute of Health Technology (KIHT) launched two major initiatives to strengthen India’s MedTech innovation ecosystem.
SVL Bioscience Pvt Ltd, a start up based within AMTZ, inaugurated its advanced clean-room facility for manufacturing rapid diagnostic kits for dengue. The company plans to expand production to include multiple parameters, making diagnostic testing more accessible and affordable for the Indian population.
Simultaneously, AMTZ unveiled a Thermoforming Technology Centre to support the production of large enclosures and customized components for medical device manufacturers, further enhancing India’s precision manufacturing capacity.
Dr Jitendra Sharma, Founder and Managing Director of AMTZ and Executive Director of KIHT, emphasized that India’s next leap lies in transforming scientific innovation into commercial success.
He announced plans for a MedTech Capital Fund to help Indian MedTech companies scale and go public, and highlighted AMTZ’s acquisition of a World Trade Centre (WTC) license making it the world’s only cluster hosting both a WHO Collaborating Centre and a WTC.
Since its inception in 2017, KIHT an initiative of the Department of Biotechnology has supported the development of over 100 indigenous medical technologies. With around 160 companies, including 30 foreign entities, operating within AMTZ, the ecosystem continues to drive innovation, policy support, and global competitiveness.
Echoing Dr. Kalam’s vision of self-reliance, KIHT COO Dr. Kavita Kachroo reaffirmed the institute’s mission to bridge research and industry, ensuring that Indian innovations translate into impactful healthcare solutions for all.